Search Results

Containing any of the words

Only of the type

A PHASE III, RANDOMIZED, OPEN-LABEL STUDY EVALUATING THE EFFICACY AND SAFETY OF GIREDESTRANT IN COMBINATION WITH PHESGO VERSUS PHESGO AFTER INDUCTION THERAPY WITH PHESGO  TAXANE IN PATIENTS WITH PREVIOUSLY UNTREATED HER2-POSITIVE, ESTROGEN RECEPTOR-POSITIVE LOCALLY-ADVANCED OR METASTATIC BREAST CANCER Drug Clinical Trial

A 24-week, multicentre, non-interventional, prospective study to describe clinical outcomes of advancing therapy with iGlarLixi in patients with T2DM sub-optimally controlled on basal insulin with or without OADs in daily practice in Saudi Arabia Drug Clinical Trial

SFDA Participates in The Occupation Day for the 7th Batch of The Custodian of The Two Holy Mosques Scholarship Students Abroad News

Successful Conclusion of the SFDA and FAO “Hack4SaferPlates” to Advance Food Safety in the Near East and North Africa Region News

Effect of Initial Combination Therapy With Sitagliptin, and Metformin on Glycemic Control in Patients With Type 2 Diabetes Awareness Article

In a Meeting with ‘Alternative Breast Milk Companies’ SFDA declares: ‘Milk Packs for Infants Under 3 Years of Age Will be Subject to Pricing’ News

Randomized, Multicenter, Multinational, Double-Blind Study to Compare the Pharmacokinetics, Efficacy, Safety and Immunogenicity of MB12 (Proposed PembrolizumabBiosimilar) versus Keytruda® in Combination with Chemotherapy for the Treatment of Patients with Advanced Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (BENITO Study) Drug Clinical Trial

On Behalf of HRH Crown Prince: HRH Prince Naif bin AbdulAziz Chairs the 9th. SFDA’s Board of Directors Meeting & Launches Several SFDA’s Projects News

Biotin,Cyanocobalamin,Folic Acid,Nicotinamide,Pyridoxine (Vitamin B6),Riboflavin,Sodium Ascorbate,Sodium Pantothenate,Thiamine New SFDA Drug Approvals

An Open Label, Multicenter, Dose Escalation Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of SBC-102 (Sebelipase Alfa) in Children With Growth Failure Due to Lysosomal Acid Lipase Deficiency Drug Clinical Trial